Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8249)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2015 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He LJ, Xie D, Hu PJ, Liao YJ, Deng HX, Kung HF, Zhu SL. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer. World J Gastroenterol 2015; 21(34): 9916-9926 [PMID: 26379396 DOI: 10.3748/wjg.v21.i34.9916] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i34/9916.htm |
| Number | Citing Articles |
| 1 |
Hyun Min Koh, Dong Chul Kim, Yu‐min Kim, Dae Hyun Song. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung. Thoracic Cancer 2019; 10(12): 2209 doi: 10.1111/1759-7714.13198
|
| 2 |
Ning Xue, Shan Xing, Weiguo Ma, Jiahe Sheng, Zhiliang Huang, Qingxia Xu. Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820935773
|
| 3 |
Litao Jia, Jiamin Chen, Chuangao Xie, Liming Shao, Zhipeng Xu, Lu Zhang. microRNA-1228⁎ impairs the pro-angiogenic activity of gastric cancer cells by targeting macrophage migration inhibitory factor. Life Sciences 2017; 180: 9 doi: 10.1016/j.lfs.2017.04.023
|
| 4 |
Julia Pohl, Ulrike B. Hendgen-Cotta, Pia Stock, Peter Luedike, Tienush Rassaf. Elevated MIF-2 levels predict mortality in critically ill patients. Journal of Critical Care 2017; 40: 52 doi: 10.1016/j.jcrc.2017.03.012
|
| 5 |
Rudranil De, Souvik Sarkar, Somnath Mazumder, Subhashis Debsharma, Asim Azhar Siddiqui, Shubhra Jyoti Saha, Chinmoy Banerjee, Shiladitya Nag, Debanjan Saha, Saikat Pramanik, Uday Bandyopadhyay. Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74–NF-κB signaling. Journal of Biological Chemistry 2018; 293(51): 19740 doi: 10.1074/jbc.RA118.003935
|
| 6 |
Nadège Kindt, Fabrice Journe, Guy Laurent, Sven Saussez. Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets. Oncology Letters 2016; 12(4): 2247 doi: 10.3892/ol.2016.4929
|
| 7 |
Meri R. Räihä, Pauli A. Puolakkainen. Tumor‐associated macrophages (TAMs) as biomarkers for gastric cancer: A review. Chronic Diseases and Translational Medicine 2018; 4(3): 156 doi: 10.1016/j.cdtm.2018.07.001
|
| 8 |
Chaimaa Moundir, Farid Chehab, Nezha Senhaji, Rachid Boufettal, Kaoutar Idouz, Driss Erguibi, Sellama Nadifi. Association of the IL-17A rs2275913 and MIF rs755622 polymorphisms with the risk of gastric and colorectal cancer. Meta Gene 2019; 22: 100605 doi: 10.1016/j.mgene.2019.100605
|
| 9 |
Rasoul Estakhri, Kourosh Masnadi Shirazi, Morteza Ghojazadeh, Gilda Ghazisoltani, Mahzad Azimpouran, Sepideh Fattahi, Jalal Farshbafi Nezhad Zoghi, Farid Karkon Shayan, Behnaz Ghamari. The diagnostic value of macrophage migration inhibitory factor, carcinoembryonic antigen, and carbohydrate antigen 19-9 in gastric cancer. Journal of Analytical Research in Clinical Medicine 2018; 6(4): 179 doi: 10.15171/jarcm.2018.029
|
| 10 |
Filipa Lopes-Coelho, Fernanda Silva, Sofia Gouveia-Fernandes, Carmo Martins, Nuno Lopes, Germana Domingues, Catarina Brito, António M Almeida, Sofia A Pereira, Jacinta Serpa. Monocytes as Endothelial Progenitor Cells (EPCs), Another Brick in the Wall to Disentangle Tumor Angiogenesis. Cells 2020; 9(1): 107 doi: 10.3390/cells9010107
|
| 11 |
Nadja Niclauss, Ines Gütgemann, Jonas Dohmen, Jörg C. Kalff, Philipp Lingohr. Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives. Cancers 2021; 13(22): 5660 doi: 10.3390/cancers13225660
|
| 12 |
Romina Mora Barthelmess, Benoit Stijlemans, Jo A. Van Ginderachter. Hallmarks of Cancer Affected by the MIF Cytokine Family. Cancers 2023; 15(2): 395 doi: 10.3390/cancers15020395
|
| 13 |
Martyna Parol‐Kulczyk, Justyna Durślewicz, Laura Blonkowska, Radosław Wujec, Arkadiusz Gzil, Daria Piątkowska, Joanna Ligmanowska, Dariusz Grzanka. Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma. The Journal of Pathology: Clinical Research 2024; 10(2) doi: 10.1002/2056-4538.12365
|
| 14 |
Li-Jun Xue, Xiao-Bei Mao, Xiao-Bei Liu, Han Gao, Ya-Nan Chen, Ting-Ting Dai, Sheng-Wen Shao, Hong-Min Chen, Xiao-Yuan Chu. Activation of CD3+ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma. Cancer Biology & Therapy 2019; 20(6): 866 doi: 10.1080/15384047.2019.1579957
|
| 15 |
Hyun Min Koh, Dong Chul Kim. Prognostic significance of macrophage migration inhibitory factor expression in cancer patients. Medicine 2020; 99(32): e21575 doi: 10.1097/MD.0000000000021575
|
| 16 |
Luai Al-Marzouki, Vivian S. Stavrakos, Sanjima Pal, Betty Giannias, France Bourdeau, Roni Rayes, Nicholas Bertos, Sara Najmeh, Jonathan D. Spicer, Jonathan Cools-Lartigue, Swneke D. Bailey, Lorenzo Ferri, Veena Sangwan. Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells. Gastric Cancer 2023; 26(1): 55 doi: 10.1007/s10120-022-01338-1
|
| 17 |
Mahsa Afkhamipour, Fatemeh Kaviani, Samaneh Dalali, Tohid Piri-Gharaghie, Abbas Doosti. Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with Helicobacter pylori pIRES2-DsRed-Express-ureF DNA Vaccines. Archivum Immunologiae et Therapiae Experimentalis 2024; 72(1) doi: 10.2478/aite-2024-0004
|
| 18 |
Lin Xin, Jiang Liu, Jun-Yan Lai, He-Song Xu, Luo-Jun Fan, Yong-Hui Zou, Qi Zhou, Zhen- Qi Yue, Jin-Heng Gan. Methionine restriction promotes the polarization of macrophages towards M1 and the immunotherapy effect of PD-L1/PD-1 blockades by inhibiting the secretion of MIF by gastric carcinoma cells. Translational Oncology 2025; 51: 102181 doi: 10.1016/j.tranon.2024.102181
|
| 19 |
Zehua Wang, Chen Chen, Jiaoyu Ai, Jiao Shu, Yi Ding, Wenjia Wang, Yaping Gao, Yongxu Jia, Yanru Qin. Identifying mitophagy-related genes as prognostic biomarkers and therapeutic targets of gastric carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data. Computers in Biology and Medicine 2023; 163: 107227 doi: 10.1016/j.compbiomed.2023.107227
|
| 20 |
Mauro Vasella, Stefan Wolf, Eamon C. Francis, Gerrit Grieb, Pablo Pfister, Gregory Reid, Jürgen Bernhagen, Nicole Lindenblatt, Epameinondas Gousopoulos, Bong-Sung Kim. Involvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema. Metabolites 2023; 13(10): 1105 doi: 10.3390/metabo13101105
|
| 21 |
In-Wha Kim, Hayoung Jang, Jae Hyun Kim, Myeong Gyu Kim, Sangsoo Kim, Jung Mi Oh. RETRACTED ARTICLE: Computational Drug Repositioning for Gastric Cancer using Reversal Gene Expression Profiles. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-39228-9
|